Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL26656220 | 1.00 | — | — | |
| Lithium Ion SCHEMBL28411406 | 1.00 | — | — | |
| Lithium Ion SCHEMBL28269112 | 1.00 | CYP3A4 (0.33) | — | |
| Lithium Ion SCHEMBL8675018 | 1.00 | CYP3A4 (0.33) | — | |
| Lithium Ion SCHEMBL1714 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL5702304 | 0.82 | — | — | |
| Lithium Ion SCHEMBL1929287 | 0.82 | — | — | |
| Water SCHEMBL1780 | 0.82 | — | — | |
| Water SCHEMBL502820 | 0.82 | — | — | |
| Lithium Ion SCHEMBL10611896 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116395658-A | Preparation method of titanium-doped lithium iron phosphate material | 陕西创普斯新能源科技有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-115583873-A | Lithium squarate material and preparation method and application thereof | 无锡零一未来新材料技术研究院有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-114933332-A | Method for producing lithium manganate by composite raw materials | 安徽博石高科新材料股份有限公司 | 2022-08-23 | — | — | CN | claimed |
| WO-2025226290-A1 | SYSTEMS AND METHODS FOR PRODUCING LITHIUM CARBONATE AND USES THEREOF | ALBEMARLE CORPORATION (US) | 2025-10-30 | — | — | WO | disclosed |
| US-12401042-B2 | Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings | Forge Nano Inc. (US) | 2025-08-26 | — | — | US | disclosed |
| US-12234147-B2 | Lithium-containing chalcophosphates for thermal neutron detection | NORTHWESTERN UNIVERSITY (US) | 2025-02-25 | — | — | US | disclosed |
| CN-119297457-A | Method for promoting pre-intercalation of lithium by waste electrode material | 哈尔滨工业大学 | 2025-01-10 | — | — | CN | disclosed |
| US-20240429437-A1 | NANO-ENGINEERED COATINGS FOR ANODE ACTIVE MATERIALS, CATHODE ACTIVE MATERIALS, AND SOLID-STATE ELECTROLYTES AND METHODS OF MAKING BATTERIES CONTAINING NANO-ENGINEERED COATINGS | Forge Nano, Inc. | 2024-12-26 | — | — | US | disclosed |
| CN-118522989-B | Free radical pre-control solid phase sintering regeneration method for failure ternary material and black powder and ternary positive electrode material | 清华大学深圳国际研究生院 | 2024-09-17 | — | — | CN | disclosed |
| CN-118619368-A | Method for repairing positive electrode active material and application thereof | 当升科技(常州)新材料有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118563101-A | Deliquescence separation and purification method | 上海科技大学 | 2024-08-30 | — | — | CN | disclosed |
| WO-2002017912-A1 | ENDOTHELIN ANTAGONISTS | ABBOTT LABORATORIES (US) | 2002-03-07 | — | — | WO | disclosed |
| WO-2002000602-A1 | BENZOPHENONES AND SULFONES AS INHIBITORS OF GLYCINE UPTAKE | PFIZER PRODUCTS INC. (US) | 2002-01-03 | — | — | WO | disclosed |
| US-6291522-B1 | OCULAR HYPOTENSIVES. | ALLERGAN SALES, INC. | 2001-09-18 | — | — | US | disclosed |
| EP-1003740-A2 | PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGOISTS | Abbott Laboratories (US) | 2000-05-31 | — | — | EP | disclosed |
| WO-1999006397-A2 | PYRROLIDINE-3-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ABBOTT LABORATORIES (US) | 1999-02-11 | — | — | WO | disclosed |
| EP-0885215-A1 | NOVEL BENZO-1,3-DIOXOLYL- AND BENZOFURANYL SUBSTITUTED PYRROLIDINE DERIVATIVES AS ENDOTHELIN ANTAGONISTS | Abbott Laboratories (US) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997030045-A1 | NOVEL BENZO-1,3-DIOXOLYL- AND BENZOFURANYL SUBSTITUTED PYRROLIDINE DERIVATIVES AS ENDOTHELIN ANTAGONISTS | ABBOTT LABORATORIES (US) | 1997-08-21 | — | — | WO | disclosed |
| EP-0776324-A1 | ENDOTHELIN ANTAGONISTS | Abbott Laboratories (US) | 1997-06-04 | — | — | EP | disclosed |
| WO-1996006095-A1 | ENDOTHELIN ANTAGONISTS | ABBOTT LABORATORIES (US) | 1996-02-29 | — | — | WO | disclosed |